Tuesday, March 24, 2026

Experts Emphasize On Holistic Framework For Semaglutide Use In Weight Management

Leading medical experts from Pune and Mumbai highlight the need for a holistic framework in managing weight loss using Semaglutide, as the global successful formulation goes off patent in India. They emphasised that sustainable outcomes depend on combining medication with well-structured diet and regular exercise.

The experts included:

• Dr. J S Hiremath – Interventional Cardiologist
• Dr. Sanjay Agarwal – Diabetologist & Internal Medicine
• Dr. Vaishali Deshmukh – Senior Endocrinologist
• Dr. Rajiv Kovil – Diabetologist

The experts described Semaglutide as a clinically proven option for managing diabetes and weight, but emphasised that it should not be used as a standalone solution or quick fix. They stressed that thorough evaluation and patient eligibility assessment are crucial before initiating treatment, and that a valid prescription must be issued by a healthcare professional after careful assessment for suitability.

Adherence to medication schedule was highlighted as a key factor in effectively managing chronic conditions such as weight gain and diabetes. The experts noted that long-term use of Semaglutide can lead to sustained improvements in blood sugar control and weight management.

They also highlighted the importance of appropriate patient counselling and routine monitoring during therapy. Most patients generally tolerate treatment well, with commonly reported side effects being mild and transient, such as nausea or a feeling of fullness, particularly in the initial phase. With gradual dose escalation and regular follow-up, these effects are usually manageable. Ongoing clinical engagement was emphasised as important to ensure good adherence and to promptly address any concerns related to tolerability or patient experience. Regular follow-ups were underscored as essential for addressing these concerns as engagement ensures that any issues related to adherence or tolerability are identified and managed promptly.

The experts also discussed patient eligibility, highlighting that some individuals may seek Semaglutide for quick weight loss, even when they do not meet the eligibility criteria. A careful evaluation and planning of the patient's weight management needs is essential while prescribing Semaglutide. This should include a structured weight loss plan with adequate protein intake and strength training to prevent muscle loss.

Patient dropout rates, often linked to inadequate side effect management, underline the necessity for specialist intervention. They also underscored the importance of dosage titration for safe and effective use.

The experts addressed the distinction between innovator Semaglutide and emerging generic versions. They highlighted that the innovator molecule is a biologic, whereas generics ones being launched are synthetic or chemical entities. Only original Semaglutide is supported by robust evidence from nearly 50 clinical trials in diverse clinical indications including outcome trials and has been taken by more than 25+ million patients worldwide for more than a decade.

Finally, the experts highlighted the importance of effective patient education in achieving better health outcomes. By ensuring that patients understand the role of Semaglutide within their overall health journey, healthcare providers can foster informed decision-making, leading to better long-term outcomes and quality of life.

Here’s what the medical experts had to opine:

Dr. Sanjay Agarwal – Diabetologist & Internal Medicine:

"Obesity is a widespread issue in India, with 70% of the population affected in some form. While traditional methods like diet and exercise offered modest weight loss, they were insufficient for individuals with a BMI above 30. The advent of semaglutide provides a promising and affordable solution to bridge the treatment gap. By reducing weight, we can significantly lower the risk of chronic diseases such as diabetes, hypertension, heart disease, and cancer."

Dr. Jagdish Hiremath – Cardiologist:

"Obesity is a major risk factor for heart disease, and its management is critical in preventing cardiovascular issues. For patients without heart disease, addressing obesity early can help prevent future complications. In those with existing heart conditions, weight loss through treatments like semaglutide can help mitigate further risks. This drug has shown significant benefits in reducing weight, improving blood pressure, cholesterol, and even conditions like obstructive sleep apnoea and heart failure. Availability of therapies like Semaglutide represents a significant advancement in clinical practice and we are fortunate to offer such therapy to our patients. He noted that this is a vital drug for clinicians, enabling more effective management of obesity, metabolic disorders and cardiometabolic risk, and must be used with due precautions and counselling in order to provide maximum benefits safely"

Dr. Rajiv Kovil – Diabetologist:

"Semaglutide marks a significant breakthrough in our ability to address the root cause of obesity and diabetes—the wrong deposition of fat in organs like the liver, pancreas, and kidneys. With each percentage of fat reduction, we see a meaningful modification in disease outcomes. By reducing weight by 10-15%, we can improve conditions like fatty liver, diabetes, osteoarthritis, and even help patients reduce their medication requirements. This drug not only reduces weight but also offers substantial protection to vital organs like the liver, kidneys, and heart."

Dr. Vaishali Deshmukh – Senior Endocrinologist:

"Obesity is not merely a lifestyle issue but a disease affecting multiple organs in the body. We must focus on adipocyte or fat health similar to any organ health and metabolic evaluation must be done along with BMI and body composition assessment to understand the true impact of obesity. Semaglutide, when combined with lifestyle changes, can help manage weight more effectively, especially when traditional methods stop working or plateau down. It offers a powerful tool in addressing obesity and its related diseases like diabetes, heart disease, hypertension and many more”

Star Alliance Opens Star Connection Centre At Los Angeles International Airport

· Strengthening seamless multi-airline connections at one of Star Alliance’s busiest transfer hubs in North America

To reinforce its commitment to delivering effortlessly connected multi-airline journeys across its global network, Star Alliance today opened a new Star Connection Centre (SCC) at LAX — its ninth centre worldwide.

With more than 350,000 passengers connecting between Star Alliance member airlines at Los Angeles International Airport (LAX) each year, it is one of the Alliance’s most critical global transfer hubs.

Designed to support passengers with tight connections between two Star Alliance member airline flights, SCC proactively identifies customers at risk of missing their onward journey due to their delayed incoming flight and expedites them to their next flight.

“Every moment matters when connections are tight, and our goal is to make multi-airline journeys feel seamless,” said Ambar Franco, Vice President - Customer Experience at Star Alliance. “At Star Connection Centres, our member airlines come together as one to ensure that, regardless of which airline passengers are flying with, they are supported from an Alliance perspective. This is what Star Alliance stands for — delivering a smooth experience across our global network. Our latest Star Connection Centre at LAX will benefit our members and customers alike.”

For Star Alliance passengers, the experience is simple: a smooth and seamless connection. Behind the scenes, however, teams across Star Alliance member airlines work together to make that possible. Dedicated agents monitor transfer windows using specialised software and step in to coordinate support — meeting passengers at the arrival gate and guiding them swiftly to their next flight.

Star Alliance has been operating Connection Centres for more than a decade, supporting both passenger and baggage transfers across key hubs worldwide. In addition to Los Angeles, Star Connection Centres are located in Brussels (BRU), Chicago (ORD), Frankfurt (FRA) and Toronto (YYZ), while dedicated baggage-focused SCC operate in Houston (IAH), Newark (EWR), Washington Dulles (IAD) and San Francisco (SFO).

At present, 16 Star Alliance member airlines serve Los Angeles: Air Canada, Air China, Air New Zealand, ANA, Asiana Airlines, Austrian, Avianca, Copa Airlines, EVA Air, LOT Polish Airlines, Lufthansa, Singapore Airlines, SWISS, TAP Air Portugal, Turkish Airlines and United. Together, they operate more than 2,000 weekly flights to over 80 destinations across more than 20 countries.

About Air India group

The Air India group – comprising of full-service global airline, Air India, and value carrier, Air India Express – is spearheading a new era of Indian aviation. The Air India story began in 1932 when JRD Tata piloted the airline’s inaugural flight and opened the skies for aviation in India. Today, Air India group employs more than 30,000 people, operates over 300 aircraft and carries customers to 58 domestic and 51 international destinations across five continents. Returning to the Tata Sons in 2022 following 70 years under Government ownership, Air India group is in the midst of a five-year transformation program, Vihaan.AI. As part of the transformation, Air India has placed an order for 600 new aircraft. In 2024, sister airlines Air Asia India and Vistara were successfully merged into Air India Express and Air India, respectively, and the Airline opened South Asia’s largest aviation training academy. A new flying school is scheduled to open in 2026, and construction of a greenfield maintenance base, to be operational in 2026, is underway. In addition to receiving new aircraft, all existing aircraft are progressively undergoing a full interior refit. With transformation underway across all facets of the business and India’s rich legacy of hospitality, Air India is committed to being a world class global airline with an Indian heart.

ICICI Prudential Life Smallcap 250 Index Fund To Enable Investors To Participate In India’s Emerging Growth Stories

· Provides exposure to 250 emerging companies across sectors to build wealth
· Rule-based, index-mirroring approach ensures disciplined investing
· Diversified portfolio enables participation in long-term growth potential

ICICI Prudential Life Insurance has launched the ICICI Prudential Life Smallcap 250 Index Fund under its Unit Linked Insurance Plans (ULIPs). The fund enables customers to participate in a broad basket of emerging listed companies and build wealth over the long term through a disciplined, index-based approach.

The fund tracks the Smallcap 250 Index, which represents 250 companies ranked 251st to 500th within the Nifty 500 universe. However, regulations may restrict the Company from investing in all the stocks in line with their weights in the index from time to time. As a result, there could be a possible tracking error. This fund provides exposure to an array of smaller listed businesses that are at the early stage of their growth journey and have the potential to scale over time.

Commenting on the launch, Mr. Manish Kumar, Chief Investment Officer, ICICI Prudential Life Insurance Company Limited, said, “The Smallcap 250 Index Fund provides customers with a simple and transparent way to participate in the growth potential of emerging companies and build wealth over the long-term. This makes it suitable for long-term investors seeking a structured exposure to the emerging companies across diverse sectors of the market.

The rule-based approach offers diversification across a wide set of businesses while remaining disciplined and aligned with the benchmark. Notably, the fund provides broad-based diversification in 250 emerging companies across sectors including Financial Services, Healthcare and Capital Goods, among others, enabling investors to participate in multiple emerging companies of the economy through a single fund.”

As of February 27, 2026, the Nifty Smallcap 250 TRI delivered 15.36% over one year, with a five-year annualised return of 19.04% and since inception return of 15.45%, reflecting its long-term growth potential. Being an equity-linked strategy, the fund’s value may fluctuate with market movements.

The investment strategy follows a passive, index-mirroring approach, aiming to stay aligned with the benchmark rather than relying on active stock selection. The index is reviewed and refreshed twice a year to remain consistent with its defined methodology, ensuring a disciplined and transparent investment process.

The ICICI Prudential Life Smallcap 250 Index Fund is available as an investment option with some of the Company’s popular ULIP products with life cover, such as ICICI Pru Signature Assure, SmartKid Assure with ICICI Pru Signature Assure, ICICI Pru Smart Insurance Plan Plus (SIP+) amongst other ULIP products available on www.iciciprulife.com.

About ICICI Prudential Life Insurance (www.iciciprulife.com)

ICICI Prudential Life Insurance Company Limited is promoted by ICICI Bank Limited and Prudential Corporation Holdings Limited. The Company began its operations in fiscal year 2001 and has consistently been amongst the top private sector life insurance companies in India on Retail Weighted Received Premium (RWRP) basis. The Company offers an array of products in the Protection and Savings category which match the different life stage requirements of customers, enabling them to provide a financial safety net to their families as well as achieve their long-term financial goals. The digital platform of the Company provides a paperless buying experience to customers, empowers them to conduct an assortment of self-service transactions, provides a convenient route to make digital payments and facilitates a hassle-free claims settlement process.

The Company has introduced ICICI Pru Stack, a first-of-its kind suite of platform capabilities that combines digital tools and analytics. This innovative suite aims to enhance the understanding of customers' requirements and enable distributors to offer suitable insurance products, deliver seamless experiences, and provide exceptional pre- and post-sale services. By deploying this comprehensive solution, the Company aspires to transform into the most customer-friendly and partnerable insurance provider in the country.

At December 31, 2025, the Company had an AUM of Rs. 3.31 lakh crore and a total in-force sum assured of Rs. 43.44 lakh crore. ICICI Prudential Life is also the first insurance company in India to be listed on both the National Stock Exchange (NSE) Limited and Bombay Stock Exchange (BSE) Limited. 

Garmin Customers Can Stay Connected With WhatsApp On Their Smartwatch


* Customers can read, reply and react to messages right from their wrist

Garmin (NYSE: GRMN) today announced a new WhatsApp app for select Garmin smartwatches, now available for free in the Connect IQ™ Store. Those with a compatible smartwatch, including select fēnix®, Forerunner®, Venu® and vívoactive® products, can quickly communicate with others - all while keeping their phone in their pocket1.

When using the WhatsApp app on their smartwatch, Garmin customers can:

View recent messages and conversations at a glance

Read and reply to messages using the built-in keyboard

Quickly send emojis and reactions to messages

See more chat history with up to 10 messages shown on screen

See incoming calls with the option to decline

As always, personal messages and calls on WhatsApp remain protected by end-to-end encryption, so only the user and the person they are talking to can read or listen to them.

Garmin customers can download the WhatsApp app now in the Connect IQ Store.

Furthering innovation through the Garmin developer program

WhatsApp is the first and only third-party messaging app currently available on Garmin smartwatches, made possible through Garmin’s robust developer program and Connect IQ platform.

“Collaborating with WhatsApp underscores the strength and momentum of the Garmin Connect IQ ecosystem. By bringing a global messaging brand like WhatsApp to select Garmin smartwatches, we’re giving customers another meaningful way to stay connected—whether they’re training, exploring or simply on the move.” —Susan Lyman, Garmin Vice President of Consumer Sales and Marketing

“WhatsApp helps people stay connected no matter what platform they use. We’re proud to bring WhatsApp to Garmin smartwatches, so that more people can keep their private conversations going right from their wrist.” —Nikhil Joshi, Director of Product Management at Meta

For those interested in building unique wearable experiences leveraging Garmin device sensors and features, click here to learn more about developing in Connect IQ.

The Connect IQ Store is an all-in-one source for Garmin customers looking to personalize their compatible Garmin devices. With thousands of options to choose from, users can download apps, watch faces, music streaming services and more right to their device. The Connect IQ Store is accessible through the Google Play and Apple App Store. For more information, email our media team or connect with us on LinkedIn.

1 Requires a paired Apple® or Android™ smartphone with the WhatsApp mobile app.

About Garmin International, Inc.

Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin, fēnix, Forerunner, Venu and vívoactive are registered trademarks and Connect IQ is a trademark of Garmin Ltd. or its subsidiaries. Apple is a trademark of Apple Inc., registered in the U.S. and other countries. Android is a trademark of Google LLC. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.

About WhatsApp

More than 3 billion people in over 180 countries use WhatsApp to stay in touch with friends and family, anytime and anywhere. WhatsApp is free and offers simple, secure, reliable messaging and calling, all over the world.

HDFC Securities Launches NxtOption To Simplify Advanced Options Trading For Traders

· An integrated platform combining strategy building, real-time analytics and execution to simplify F&O trading for India’s growing retail investor base

· Designed to eliminate fragmented workflows, NxtOption brings institutional-grade options analytics and seamless multi-leg execution to a single interface

HDFC Securities today launched NxtOption, a next-generation platform designed to help retail investors analyse, build, and execute Futures & Options (F&O) strategies. The platform aims to simplify derivatives trading by integrating analytics, strategy tools, and execution into a single interface, addressing the growing demand for sophisticated trading solutions in India. This launch further reinforces HDFC Securities’ commitment to ‘Powering India’s Investments’ by supporting investor participation in the capital markets through integrated tools and analytics.

Leadership Comment:

“Derivatives trading has become an important part of the Indian markets, but the rapid rise in retail participation has also highlighted key gaps in the ecosystem. A significant portion of trading remains speculative, with many participants lacking access to structured strategies, risk frameworks, and actionable insights. Execution inefficiencies, especially in multi-leg strategies, further impact outcomes. With NxtOption, we aim to bridge this gap by making professional-grade analytics and seamless execution more accessible, enabling a shift towards more disciplined, strategy-led trading and providing tools to assist investors in evaluating strategies more systematically,” said Dhiraj Relli, Managing Director & CEO, HDFC Securities.

What is NxtOption?

NxtOption is an integrated options trading platform by HDFC Securities that allows users to build multi-leg F&O strategies, analyse risk and payoff scenarios, execute trades seamlessly, and track strategies in real time. Unlike traditional setups that require multiple tools, NxtOption brings everything together into one unified interface.

Why is HDFC Securities launching NxtOption now?

India’s derivatives market has seen rapid growth in retail participation, but most traders still rely on multiple platforms, manual calculations, and fragmented workflows. NxtOption addresses this gap by offering a single platform that simplifies strategy analysis, risk management, and trade execution, in line with the firm’s broader vision of ‘Powering India’s Investments’ through innovation-led solutions.

What are the key Features of NxtOption?

a. Strategy Builder: Create and evaluate strategies before trading by building multi-leg strategies such as Straddles, Strangles, Iron Condors, and Butterflies. NxtOption allows users to view payoff charts, break-even points, profit and loss scenarios, combined Greeks, and margin requirements.

b. Strategy Watch: Allows users to track strategies as a whole and monitor complete strategies instead of individual legs, thereby enabling real-time tracking of strategy-level performance.

c. Easy Options: Provides strategy suggestions by converting a user’s market view (bullish, bearish, neutral) into relevant strategy ideas. It also enables users to view corresponding risk-reward profiles and is designed especially for new and evolving traders.

d. Advanced Derivatives Analytics: Provides real-time insights into Delta, Gamma, Theta, Vega, Implied Volatility (IV), Open Interest (OI) trends, as well as time value and intrinsic value. It also includes features such as market movers, rollover insights, and F&O ban list tracking.

How is NxtOption Different from Other Trading Platforms?

NxtOption stands out by eliminating the need for multiple tools. It offers an end-to-end workflow (idea → analysis → execution) and combines institutional-grade analytics with retail accessibility.

Where is NxtOption available for the traders to access?

NxtOption is available across mobile (InvestRight) and the web platform of HDFC Securities, as well as on the web platform of HDFC SKY, the discount broking offering.

To support users in evaluating options strategies through structured analytical features, the platform also introduces Easy Options, a feature that converts a trader’s market outlook into potential strategy suggestions. For example, if a trader has a bullish view on the Nifty over a particular timeframe, the system suggests suitable options strategies along with their risk-reward profiles.

With the introduction of NxtOption, HDFC Securities continues to provide technology-enabled tools for users engaging with derivatives markets in India, by combining analytics, strategy creation, and execution into a single trading experience thereby further strengthening its role in ‘Powering India’s Investments’ at scale.

For more information on NxtOption, visit:

https://investright.onelink.me/Xwlu/viy5q4er

Quality Care India Limited Signs MoU With Bangalore Based Intuitive To Expand Robotic-Assisted Surgery In Tier 2 & 3 Markets


· QCIL will scale its robotic-assisted surgery programme through a phased multi-system installation plan across its hospital network

· The collaboration will strengthen clinical capability through structured training pathways and ongoing service support for surgeons and care teams

· The initiative aims to expand access to minimally invasive care across specialties, bringing advanced treatment closer to patients beyond major metros.

Quality Care India Ltd. (QCIL), one of India’s leading healthcare platforms, has signed a Memorandum of Understanding (MoU) with Bangalore based Intuitive, a global technology leader in minimally invasive care and pioneer of robotic-assisted surgery (RAS), to scale robotic-assisted surgery across its multi-brand hospital network comprising CARE Hospitals, KIMSHEALTH and Evercare Hospitals through a phased multi-system installation plan. The initiative will strengthen clinical capabilities while extending advanced minimally invasive care to patients in tier 2 and tier 3 markets.

The expansion of robotic-assisted surgery aligns with QCIL’s broader strategy to strengthen advanced surgical infrastructure in emerging healthcare markets. This collaboration will help scale its adoption across additional centres, strengthening clinical capacity and access to robotic-assisted surgery for patients across regions. The expanded deployment will support surgeons and care teams in delivering robotic-assisted procedures across specialties, including Thoracic, Transplant, urology, gynaecology, general surgery, and surgical oncology.

Commenting on the collaboration, Varun Khanna, Group Managing Director, Quality Care India Limited, said, “Scaling robotic-assisted surgery across centres requires a structured approach that strengthens clinical capability and programme consistency. Through this collaboration, we will focus on building readiness across teams and specialties so that more patients can access advanced minimally invasive care closer to home as we expand into tier 2 and tier 3 markets. This initiative reflects our commitment to delivering world-class surgical infrastructure beyond metropolitan cities and improving access to high-end clinical interventions across India.”

Rohitt Mahajan, Vice President and General Manager, Intuitive India, added, "We are pleased to collaborate with QCIL as they expand robotic-assisted surgery capabilities across their hospital network in the region. By combining our strengths, we aim to broaden patient access to advanced minimally invasive care, enabling faster recoveries and helping patients return sooner to what matters most in their lives. We are honored to partner with QCIL’s visionary leadership, whose commitment to innovation and patient-centric care aligns strongly with our shared mission to make a meaningful impact on the lives of patients across the region.”

As part of the MoU, Intuitive will provide comprehensive technology training, customer service, and support to surgeons and care teams across QCIL’s network hospitals, strengthening programme adoption, procedural consistency, and scalable implementation across centres. The QCIL hospitals to have a faster recovery & precise surgery, thereby improving clinical outcomes. There are currently over 200 da Vinci systems installed across India, with more than 1,500 surgeons trained in robotic-assisted surgery in specialties such as gynaecology, urology, general surgery, and oncology. Collectively, there have been more than 16.9 million da Vinci procedures performed globally to date, with more than 43,000 peer-reviewed scientific articles referencing da Vinci and related technologies. Intuitive has supported over 35 clinical studies in India, generating local evidence that supports structured and evidence-based program development across institutions.

The collaboration reflects a shared commitment to building structured, scalable, and outcome-driven robotic surgery programmes that integrate technology, training, and clinical oversight to ensure consistent patient outcomes across diverse geographies.

Monday, March 23, 2026

Tata AIA Life Insurance Launches Three New Funds In Indian Market


* Large Mid Cap Innovation Fund, Large Mid Cap Innovation Pension Fund, and Global AI & Technology Leaders Fund

Tata AIA Life Insurance, a leading private life insurance company in India, today launched three new funds offering investors a unique opportunity to capitalize on India’s growth potential and global technological advancements, all while benefiting from life insurance protection through Tata AIA’s Unit Linked Insurance Plans (ULIPs).

Investors can explore more information about these funds and Tata AIA’s investment solutions at www.tataaia.com.

The Tata AIA Large Mid Cap Innovation Fund, Tata AIA Large Mid Cap Innovation Pension Fund, and Tata AIA Global AI & Technology Leaders Fund are strategically designed to help investors capture opportunities from India’s innovation-driven sectors and global technological breakthroughs.
These funds governed and regulated as per IFSC regulations.

Tata AIA Large Mid Cap Innovation Fund- (SFIN: ULIF 099 31/03/26 LMI 110) | Tata AIA Large Mid Cap Innovation Pension Fund- (SFIN: ULIF 100 31/03/26 LMP 110)

* TATA AIA Global AI and Technology Leaders Fund- (SFIN: ULIF 504 31/03/26 TGT 110)

New Fund Offer (NFO) Details:

NFO Period: 24 March to 31 March 2026

Units Issued at NAV: ₹10 for domestic funds, $10 for global fund at midnight on 31 March 2026

Harshad Patil, Chief Investment Officer, Tata AIA Life Insurance, commented, “Innovation is reshaping economies, both in India and globally. With the launch of the Tata AIA Large Mid Cap Innovation Fund, Tata AIA Large Mid Cap Innovation Pension Fund, and the Tata AIA Global AI & Technology Leaders Fund, we are providing our policyholders with the opportunity to invest in these transformative sectors while continuing to benefit from the protection of life insurance. This is the right moment for investors to capitalize on these opportunities and secure their financial future.”

Tata AIA Large Mid Cap Innovation Fund: Capitalizing on India’s Innovation-Driven Growth

India’s economy is undergoing significant digital transformation, with innovative companies driving growth across various sectors. The Tata AIA Large Mid Cap Innovation Fund is focused on investing in India’s large and mid-cap companies that are leading this transformation, aiming for long-term capital appreciation.

This fund is an excellent option for investors looking to tap into India’s next phase of economic growth driven by innovation.

Tata AIA Large Mid Cap Innovation Pension Fund: Supporting Long-Term Retirement Planning

Exclusively available through Tata AIA Life’s unit-linked pension solutions, the Tata AIA Large Mid Cap Innovation Pension Fund has been designed for those planning for retirement. It provides exposure to India’s innovative companies while enabling policyholders to build long-term wealth through a structured pension plan framework. This fund combines long-term equity growth potential with life insurance cover, ensuring that policyholders can systematically build their retirement corpus while safeguarding their family’s financial future. This fund is ideal for individuals looking to build a strong retirement corpus while participating in India’s innovation-driven growth story.

Key Features:

· Actively managed equity strategy targeting innovative companies

Equity allocation between 60% and 100%

Up to 40% allocation to debt and money market instruments

Benchmark: NSE 500 Index

Available through Tata AIA’s ULIP solutions, combining wealth creation with life insurance protection
**Benchmark Fund: NSE 500 Index. Data as of February, 2026.Source: https://www.niftyindices.com/market-data/return-profile

Tata AIA Global AI & Technology Leaders Fund: Seizing Global Opportunities in AI and Semiconductors

Alongside India’s domestic innovation, Tata AIA offers investors global exposure through the Tata AIA Global AI & Technology Leaders Fund, which focuses on artificial intelligence and semiconductor innovations. The fund tracks an index of global leaders in these sectors, providing diversified exposure to companies driving advancements in AI technology, semiconductors, cloud infrastructure, and digital platforms.

Key Features:

Passive investment strategy tracking global AI and technology leaders

Equity exposure between 70% and 100%

Available through Tata AIA Shubh Global Invest, combining global exposure with life insurance protection

This fund offers a unique opportunity to diversify portfolios globally while benefiting from the transformative potential of AI and semiconductor technologies.

Tata AIA Shubh Global Invest (USD Denominated) - Non-Participating, Unit Linked, Individual Life Insurance Savings Plan (UIN: TALL003V02)

Why Now is the Right Time to Invest

Both India and the world are experiencing rapid technological advancements. The Tata AIA Large Mid Cap Innovation Fund offers exposure to India’s innovation-driven growth, while the Tata AIA Global AI & Technology Leaders Fund allows investors to tap into global technological opportunities. Additionally, the Tata AIA Large Mid Cap Innovation Pension Fund provides a structured way for investors to plan for retirement while capitalizing on India’s growing innovation ecosystem.

Investing now offers a timely opportunity to benefit from these long-term megatrends, while securing life insurance protection through Tata AIA’s ULIP solutions. Both funds are well-positioned to capture significant growth, making this the ideal time to invest.

For more details, visit www.tataaia.com.

Product Availability

The Tata AIA Large Mid Cap Innovation Fund will be available across several of the company’s unit linked insurance plans, including solutions within Tata AIA Shubh Muhurat ,Tata AIA Shubh Fortune, Tata AIA Smart Sampoorna Raksha Pro, Tata AIA Param Raksha Life Pro, Tata AIA Smart Sampoorna Raksha Supreme, Tata AIA Shubh Health Plus ,Tata AIA Premier SIP, Tata AIA Param Raksha Life Advantage+, Tata AIA Param Raksha Life Maxima+, Tata AIA iSIP (Systematic Insurance Plan), Tata AIA Param Raksha Plus 2.0, Tata AIA Smart Sampoorna Raksha, Tata AIA Smart SIP, Tata AIA Param Raksha Life, Tata AIA Param Raksha Life Growth+, Tata AIA Param Raksha Life Pro Advance, Tata AIA Health Pro, Tata AIA Pro-Fit, Tata AIA Fortune Pro, Tata AIA Fortune Maxima, Tata AIA Wealth Pro, Tata AIA Wealth Maxima, Tata AIA Smart Sampoorna Raksha Plus, Tata AIA Smart Fortune Plus.
This enables customers across protection, savings and wealth oriented solutions to integrate innovation led equity exposure into their long term financial planning.

The Tata AIA Large Mid Cap Innovation Pension Fund will be offered through Tata AIA’s unit linked pension solutions, including Tata AIA Smart Pension Secure Plan and Tata AIA Premier Pension Secure, enabling policyholders to build a retirement corpus through market linked investments.

Customers can review availability across solutions and detailed fund information on www.tataaia.com.

Strong Growth in Assets Under Management
As of 28 February 2026, Tata AIA Life Insurance’s Assets Under Management (AUM) stood at ₹145,795 crore, reflecting 23% year on year growth. This growth has been supported by strong individual new business premium income and consistent investment performance across its fund portfolio.

Risk Note
Investors should carefully assess their risk appetite before investing as the fund carries a high-risk profile. Past performance is not indicative of future results.

Disclaimers:

· The linked insurance product do not offer any liquidity during the first five years of the contract. The policy holder will not be able to surrender/withdraw the monies invested in linked insurance products completely or partially till the end of the fifth year.

· Tata AIA Large Mid Cap Innovation Fund is a part of a various funds which a policyholder can choose from. For further details on funds, refer the sales brochure.

· Tata AIA Premier SIP is a combination of the Tata AIA Smart SIP, a non-participating, unit-linked, individual life insurance savings plan (UIN: 110L174V02), and Tata AIA Health Buddy, Non-participating, Non-Linked, Individual Health Product (UIN:110N183V01). Both Tata AIA Smart SIP and Tata AIA Health Buddy are also available for sale individually.

· Param Raksha Life Pro + is designed for combination of benefits of following individual and separate products named (1) Tata AIA Smart Sampoorna Raksha Supreme Unit Linked, Non-Participating Individual Life Insurance Plan (UIN: 110L179V02) and (2) Tata AIA Health Buddy, Non-Participating, Non-Linked, Individual Health Product (UIN: 110N183V01). These products are also available for sale individually without the combination offered/ suggested.

· Param Raksha Life Pro is designed for combination of benefits of following individual and separate products named (1) Tata AIA Smart Sampoorna Raksha Supreme Unit Linked, Non-Participating Individual Life Insurance Plan (UIN: 110L179V02) and (2) Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN:110N183V01). These products are also available for sale individually without the combination offered/ suggested.

· Param Raksha Life Maxima + is designed for combination of benefits of following individual and separate products named (1) Tata AIA Smart Sampoorna Raksha Supreme Unit Linked, Non-Participating Individual Life Insurance Plan (UIN: 110L179V02) and (2) Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN:110N183V01). These products are also available for sale individually without the combination offered/ suggested.

· Param Raksha Life Growth + is designed for combination of benefits of following individual and separate products named (1) Tata AIA Smart Sampoorna Raksha Supreme Unit Linked, Non-Participating Individual Life Insurance Plan (UIN: 110L179V02) and (2) Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN:110N183V01). These products are also available for sale individually without the combination offered/ suggested.

· Param Raksha Life Advantage + is designed for combination of benefits of following individual and separate products named (1) Tata AIA Smart Sampoorna Raksha Supreme Unit Linked, Non-Participating Individual Life Insurance Plan (UIN: 110L179V02) and (2) Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN:110N183V01). These products are also available for sale individually without the combination offered/ suggested.

· Param Raksha Life Pro Advance is designed for combination of benefits of following individual and separate products named (1) Tata AIA Smart Sampoorna Raksha Supreme Unit Linked, Non-Participating Individual Life Insurance Plan (UIN: 110L179V02) and (2) Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN:110N183V01). These products are also available for sale individually without the combination offered/ suggested.

· Tata AIA Smart Fortune Plus - Non-Participating, Unit Linked Individual Life Insurance Savings Plan (UIN: 110L177V01)

· Tata AIA Pro-Fit comprises of Tata AIA Health Pro, A Non-Participating, Unit-linked, Individual Health Insurance Plan (UIN: 110L180V01), Tata AIA Health Secure, A Non- Participating, Unit Linked, Individual Health rider (UIN: 110A050V01) & Tata AIA Health Buddy, - Non-participating, Non-Linked, Individual Health Product (UIN:110N183V01).

· The complete name of Tata AIA Wealth Pro is Tata AIA Life Insurance Wealth Pro (UIN: 110L111V05) – Non-Participating, Unit Linked, Individual Life Insurance Savings Plan

· The complete name of Tata AIA Fortune Pro is Tata AIA Life Insurance Fortune Pro (UIN: 110L112V07) – Non-Participating, Unit Linked Individual Life Insurance Savings Plan.

· The complete name of Tata AIA Wealth Maxima is Tata AIA Life Insurance Wealth Maxima – Non-Participating, Unit Linked Individual Life Insurance Savings Plan (UIN:110L114V05)

· The complete name of Tata AIA Fortune Maxima is Tata AIA Life Insurance Fortune Maxima - Non-Participating, Unit Linked Individual Life Insurance Savings Plan (UIN: 110L113V09)

· Tata AIA Smart SIP - Non-Participating, Unit Linked Individual Life Insurance Savings Plan (UIN:110L174V02)

· Shubh Muhurat Solution is a combination of Tata AIA Life Insurance Fortune Guarantee Secure (Individual, Non-Linked, Non-Participating, Life Insurance Savings Plan) UIN:110N206V03 and Tata AIA Life Insurance Smart Fortune Plus (Unit Linked, Individual Life Insurance Savings Plan)-UIN:110L177V01. Tata AIA Life Insurance Fortune Guarantee Secure and Tata AIA Life Insurance Smart Fortune Plus are also available for sale individually.

· Shubh Fortune Solution is a combination of Tata AIA Life Insurance Fortune Guarantee Secure (Individual, Non-Linked, Non-Participating, Life Insurance Savings Plan) UIN:110N206V03 and Tata AIA Life Insurance Smart Fortune Plus (Unit Linked, Individual Life Insurance Savings Plan)-UIN:110L177V01. Tata AIA Life Insurance Fortune Guarantee Secure and Tata AIA Life Insurance Smart Fortune Plus are also available for sale individually.

· Tata AIA i Systematic Insurance Plan - Non-Participating. Unit Linked Individual Life Insurance Savings Plan (UIN:110L164V10)

· Tata AIA Health SIP - A Non-participating, Unit Linked, Individual Health Insurance Plan (UIN:110L184V01)

· Tata AIA Shubh Health Plus comprises of Tata AIA Health SIP - A Non-Participating, Unit-linked, Individual Health Insurance Plan (UIN: :110L184V01), Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN: 110N183V01 or any other later version). Tata AIA Health SIP and Tata AIA Health Buddy are also available individually for sale.

· Tata AIA Smart Pension Secure (UIN: 110L182V08) - Non-Participating, Unit Linked, Individual Life Insurance Pension Plan

· Tata AIA Shubh Global Invest is the Unit linked insurance product with Tata AIA as its prefix - is only the name of the Unit Linked Life Insurance contract and does not in any way indicate the quality of the contract, its future prospects or returns. Shubh Global Invest is also available through online mode on the Company’s website www.international.tataaia.com

Tata AIA Premier Pension Secure is a combination of Tata AIA Smart Pension Secure (UIN: 110L182V08) is a Non-Participating, Unit Linked, Individual Life Insurance Pension Plan and Tata AIA Health Buddy, A Non-linked, Non-participating, Individual Health Product (UIN: 110N183V01.

Total Pageviews